CDK12 and breast cancer: While in WT mice the appearance of palpable mammary tumors was a rare event, which first appeared after 22 weeks post-treatment, adult CDK12-KI mice exhibited a dramatically high tumor penetrance and multiplicity rate, accompanied by a significantly decreased tumor latency and survival rate (Fig. 1e–g).